- Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial
[作者：Ong, KT; Perdu, J; De Backer, J; Bozec, E; Collignon, P; Emmerich, J; Fauret, AL; Fiessinger, JN; Germain, DP; Georgesco, G; Hulot, JS; De Paepe, A; Plauchu, H; Jeunemaitre, X; Laurent, S; Boutouyrie, P,期刊：Lancet, 页码：1476-1484 , 文章类型： Article，,卷期：2010年376-9751]
- Background Vascular Ehlers-Danlos syndrome is a rare severe disease that causes arterial dissections and ruptures that can lead to early death. No preventive treatment has yet been validated. Our aim was to assess the ab...
- Antiphospholipid syndrome
[作者：Ruiz-Irastorza, G; Crowther, M; Branch, W; Khamashta, MA,期刊：Lancet, 页码：1498-1509 , 文章类型： Article，,卷期：2010年376-9751]
- The antiphospholipid syndrome causes venous, arterial, and small-vessel thrombosis; pregnancy loss; and preterm delivery for patients with severe pre-eclampsia or placental insufficiency. Other clinical manifestations ar...
|